Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Technology
E-089-2002
Patent ID
E-089-2002-1-BR-05
Country
BR
Application Type
National Stage
Patent Status
Expired
Patent Number
 
Publication Number
 
Application Number
PI0309631-9
IC
NIAID
Date Filed
Date Issued
Patent PDF
 
Related Technologies
TAB-671     Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4